BTC Health Ltd (ASX: BTC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
BTC Health Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$21.07 million
P/E Ratio
19.70
Dividend Yield
0.00%
Shares Outstanding
324.12 million
Earnings per share
-0.030
Dividend per share
N/A
Year To Date Return
-13.46%
Earnings Yield
5.08%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
BTC Health Ltd (ASX: BTC)
Latest News
⏸️ Investing
6 listed funds with tax free capital gains and dividends
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 05 Jul 2011 | $0.0280 | 0.00% | Special Cash | 15 Jul 2011 |
| 03 Sep 2010 | $0.0140 | 0.00% | Final | 13 Sep 2010 |
BTC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About BTC Health Ltd
BTC Health Ltd is a pooled development fund. The company is seeking new investment opportunities in entities operating in the biotechnology/life-science sectors. Its only operating segment is the making and managing of healthcare ventures.The company's products include Rythmic Infusion Pumps, Elasto-Q, ambIT, Infusion and Nerve Catheter Kits, Tiva, Rebellion - Bone Removal System, Ilumark, COLIBRI, ECMOLIFE, ECLS Heaters Coolers.
BTC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 22 Oct 2024 | $0.07 | $0.00 | 0.00% | 191,493 | $0.06 | $0.07 | $0.06 |
| 21 Oct 2024 | $0.06 | $0.00 | 0.00% | 97,963 | $0.06 | $0.06 | $0.06 |
| 18 Oct 2024 | $0.07 | $0.00 | 0.00% | 221,765 | $0.07 | $0.07 | $0.06 |
| 16 Oct 2024 | $0.07 | $0.00 | 0.00% | 277 | $0.07 | $0.07 | $0.07 |
| 15 Oct 2024 | $0.07 | $0.00 | 0.00% | 118,892 | $0.06 | $0.07 | $0.06 |
| 14 Oct 2024 | $0.07 | $0.00 | 0.00% | 50,000 | $0.07 | $0.07 | $0.07 |
| 09 Oct 2024 | $0.07 | $0.00 | 0.00% | 40,001 | $0.07 | $0.07 | $0.07 |
| 08 Oct 2024 | $0.07 | $0.00 | 0.00% | 15,128 | $0.07 | $0.07 | $0.07 |
| 07 Oct 2024 | $0.07 | $0.00 | 0.00% | 4,000 | $0.07 | $0.07 | $0.07 |
| 04 Oct 2024 | $0.07 | $0.00 | 0.00% | 109 | $0.07 | $0.07 | $0.07 |
| 03 Oct 2024 | $0.07 | $0.00 | 0.00% | 10,000 | $0.07 | $0.07 | $0.07 |
| 01 Oct 2024 | $0.07 | $0.00 | 0.00% | 21,531 | $0.07 | $0.07 | $0.07 |
| 30 Sep 2024 | $0.07 | $0.00 | 0.00% | 28,977 | $0.07 | $0.07 | $0.07 |
| 26 Sep 2024 | $0.07 | $0.00 | 0.00% | 377,202 | $0.07 | $0.07 | $0.06 |
| 25 Sep 2024 | $0.06 | $0.01 | 17.24% | 80,680 | $0.06 | $0.06 | $0.06 |
| 24 Sep 2024 | $0.06 | $0.00 | 0.00% | 24,000 | $0.06 | $0.06 | $0.06 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 27 Jun 2024 | Richard Treagus | Buy | 185,515 | $7,094 |
On-market trade.
|
| 22 Nov 2023 | Richard Treagus | Issued | 10,000,000 | $600,000 |
Issue of options.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr Richard Spencer Treagus | Executive ChairmanExecutive Director | Aug 2014 |
Dr Treagus has over 25 years of experience in all aspects of the international pharmaceutical and biotechnology industry.
|
| Mr Brendan York | Non-Executive Director | Oct 2022 |
Mr York has over 20 years ofexperience across public and private businesses. Brendan is currently portfolio manager of Naos Asset Management Limited.
|
| Ms Felicity McNeill | Non-Executive Director | Oct 2022 |
Ms McNeill has over 25 years of experience across the public and private sector including almost 15 years in the regulatory and subsidy systems for medicines, vaccines, devices and diagnostics in Australia.
|
| Ms Tracy Weimar | Company Secretary | Aug 2023 |
-
|
| Tracy Weimar | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| J P Morgan Nominees Australia Pty Limited | 94,738,597 | 29.23% |
| Mrs Karen Elizabeth Treagus | 29,561,515 | 9.12% |
| Sigma Company Limited | 16,856,467 | 5.20% |
| Namarong Investments Pty Ltd | 15,000,000 | 4.63% |
| Kingfisher Medical Pty Ltd | 14,092,318 | 4.35% |
| Glk Medical Pty Ltd | 14,092,318 | 4.35% |
| Tau Investments Australia Pty Ltd | 14,092,318 | 4.35% |
| Mr Thomas Christopher Fennell | 8,682,787 | 2.68% |
| Mr Campbell Dinwoodie Taylor | 8,393,127 | 2.59% |
| Sigma Company Limited i | 8,143,533 | 2.51% |
| Argus Nominees Pty Ltd | 5,500,000 | 1.70% |
| Mrs Susan Maree Whiting | 5,300,000 | 1.64% |
| Citicorp Nominees Pty Limited | 4,543,617 | 1.40% |
| Windarri Investments Pty Ltd | 4,213,727 | 1.30% |
| Abeille Investments Pty Limited | 3,800,000 | 1.17% |
| Mr Nicholas Dermott Mcdonald | 3,644,239 | 1.12% |
| Sigma Company Limited ii | 3,627,553 | 1.12% |
| Namarong Investments Pty Ltd i | 3,125,000 | 0.96% |
| Linwierik Investments Pty Ltd | 2,600,000 | 0.80% |
| Chanuk Nominees Pty Ltd | 2,000,000 | 0.62% |
| Pritdown Pty Ltd | 2,000,000 | 0.62% |
